Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. | LitMetric

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 197

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1075
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3195
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 317
Function: require_once

Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. | LitMetric

Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials.

April W Armstrong , Matthias Augustin , Jennifer L Beaumont , Tan P Pham , Stacie Hudgens , Kenneth B Gordon , Joe Zhuo , Brandon Becker , Yichen Zhong , Renata M Kisa , Subhashis Banerjee , Kim A Papp

Dermatol Ther (Heidelb)

Alliance Clinical Trials and Probity Medical Research, Waterloo, ON, Canada.

Published: April 2025

Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Download full-text PDF
Source

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11971066 PMC
http://dx.doi.org/10.1007/s13555-024-01317-7 DOI Listing

Publication Analysis

Top Keywords

correction deucravacitinib

4

deucravacitinib improves

4

improves patient-reported

4

patient-reported outcomes

4

outcomes patients

4

patients moderate

4

moderate severe

4

severe psoriasis

4

psoriasis phase

4

phase randomized

4

Similar Publications